Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
|
|
|
9.
|
|
|
|
10.
|
|
|
|
11.
|
|
|
|
12.
|
|
|
|
13.
|
|
|
|
14.
|
|
|
|
15.
|
|
|
|
16.
|
|
|
|
17.
|
|
|
|
18.
|
|
|
|
19.
|
Siltuximab (CNTO 328) with lenalidomide, bortezomib and dexamethasone in newly-diagnosed, previously untreated multiple myeloma: an open-label phase I trial. [electronic resource] by
- Shah, J J
- Feng, L
- Thomas, S K
- Berkova, Z
- Weber, D M
- Wang, M
- Qazilbash, M H
- Champlin, R E
- Mendoza, T R
- Cleeland, C
- Orlowski, R Z
Producer: 20161013
In:
Blood cancer journal vol. 6
Availability: No items available.
|
|
|
20.
|
Targeting nucleolin for better survival in diffuse large B-cell lymphoma. [electronic resource] by
- Jain, N
- Zhu, H
- Khashab, T
- Ye, Q
- George, B
- Mathur, R
- Singh, R K
- Berkova, Z
- Wise, J F
- Braun, F K
- Wang, X
- Patel, K
- Xu-Monette, Z Y
- Courty, J
- Young, K H
- Sehgal, L
- Samaniego, F
Producer: 20190208
In:
Leukemia vol. 32
Availability: No items available.
|